<VariationArchive VariationID="11458" VariationName="NM_001099857.5(IKBKG):c.1166_1178dup (p.Asp394fs)" VariationType="Duplication" Accession="VCV000011458" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2019-02-23" MostRecentSubmission="2024-07-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26497" VariationID="11458">
      <GeneList>
        <Gene Symbol="IKBKG" FullName="inhibitor of nuclear factor kappa B kinase regulatory subunit gamma" GeneID="8517" HGNC_ID="HGNC:5961" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154541238" stop="154565046" display_start="154541238" display_stop="154565046" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153770458" stop="153793260" display_start="153770458" display_stop="153793260" Strand="+" />
          </Location>
          <OMIM>300248</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001099857.5(IKBKG):c.1166_1178dup (p.Asp394fs)</Name>
      <CanonicalSPDI>NC_000023.11:154564364:CCCCGAGGAGCCACC:CCCCGAGGAGCCACCCCGAGGAGCCACC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154564364" stop="154564365" display_start="154564364" display_stop="154564365" variantLength="13" positionVCF="154564364" referenceAlleleVCF="C" alternateAlleleVCF="CCCCCGAGGAGCCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153792579" stop="153792580" display_start="153792579" display_stop="153792580" variantLength="13" positionVCF="153792579" referenceAlleleVCF="C" alternateAlleleVCF="CCCCCGAGGAGCCA" />
      </Location>
      <ProteinChange>D295fs</ProteinChange>
      <ProteinChange>D393fs</ProteinChange>
      <ProteinChange>D271fs</ProteinChange>
      <ProteinChange>D342fs</ProteinChange>
      <ProteinChange>D394fs</ProteinChange>
      <ProteinChange>D462fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153792582_153792594dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153792582_153792594dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154564367_154564379dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154564367_154564379dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009896.1" sequenceAccession="NG_009896" sequenceVersion="1" change="g.27124_27136dup">
            <Expression>NG_009896.1:g.27124_27136dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099856.6" sequenceAccession="NM_001099856" sequenceVersion="6" change="c.1370_1382dup">
            <Expression>NM_001099856.6:c.1370_1382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001093326.2" sequenceAccession="NP_001093326" sequenceVersion="2" change="p.Asp462fs">
            <Expression>NP_001093326.2:p.Asp462fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099857.5" sequenceAccession="NM_001099857" sequenceVersion="5" change="c.1166_1178dup" MANESelect="true">
            <Expression>NM_001099857.5:c.1166_1178dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001093327.1" sequenceAccession="NP_001093327" sequenceVersion="1" change="p.Asp394fs">
            <Expression>NP_001093327.1:p.Asp394fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145255.4" sequenceAccession="NM_001145255" sequenceVersion="4" change="c.869_881dup">
            <Expression>NM_001145255.4:c.869_881dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138727.1" sequenceAccession="NP_001138727" sequenceVersion="1" change="p.Asp295fs">
            <Expression>NP_001138727.1:p.Asp295fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321396.3" sequenceAccession="NM_001321396" sequenceVersion="3" change="c.1166_1178dup">
            <Expression>NM_001321396.3:c.1166_1178dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308325.1" sequenceAccession="NP_001308325" sequenceVersion="1" change="p.Asp394fs">
            <Expression>NP_001308325.1:p.Asp394fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321397.3" sequenceAccession="NM_001321397" sequenceVersion="3" change="c.1163_1175dup">
            <Expression>NM_001321397.3:c.1163_1175dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308326.1" sequenceAccession="NP_001308326" sequenceVersion="1" change="p.Asp393fs">
            <Expression>NP_001308326.1:p.Asp393fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377312.1" sequenceAccession="NM_001377312" sequenceVersion="1" change="c.1166_1178dup">
            <Expression>NM_001377312.1:c.1166_1178dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364241.1" sequenceAccession="NP_001364241" sequenceVersion="1" change="p.Asp394fs">
            <Expression>NP_001364241.1:p.Asp394fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377313.1" sequenceAccession="NM_001377313" sequenceVersion="1" change="c.1163_1175dup">
            <Expression>NM_001377313.1:c.1163_1175dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364242.1" sequenceAccession="NP_001364242" sequenceVersion="1" change="p.Asp393fs">
            <Expression>NP_001364242.1:p.Asp393fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377314.1" sequenceAccession="NM_001377314" sequenceVersion="1" change="c.1010_1022dup">
            <Expression>NM_001377314.1:c.1010_1022dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364243.1" sequenceAccession="NP_001364243" sequenceVersion="1" change="p.Asp342fs">
            <Expression>NP_001364243.1:p.Asp342fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377315.1" sequenceAccession="NM_001377315" sequenceVersion="1" change="c.797_809dup">
            <Expression>NM_001377315.1:c.797_809dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364244.1" sequenceAccession="NP_001364244" sequenceVersion="1" change="p.Asp271fs">
            <Expression>NP_001364244.1:p.Asp271fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003639.4" sequenceAccession="NM_003639" sequenceVersion="4" change="c.1166_1178dup">
            <Expression>NM_003639.4:c.1166_1178dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003630.1" sequenceAccession="NP_003630" sequenceVersion="1" change="p.Asp394fs">
            <Expression>NP_003630.1:p.Asp394fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_165197.1" sequenceAccession="NR_165197" sequenceVersion="1" change="n.1035_1047dup">
            <Expression>NR_165197.1:n.1035_1047dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_70" sequenceAccession="LRG_70">
            <Expression>LRG_70:g.27124_27136dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300248.0012" DB="OMIM" />
        <XRef Type="rs" ID="2071167272" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001099857.5(IKBKG):c.1166_1178dup (p.Asp394fs) AND Incontinentia pigmenti syndrome" Accession="RCV000012213" Version="20">
        <ClassifiedConditionList TraitSetID="3124">
          <ClassifiedCondition DB="MedGen" ID="C0021171">Incontinentia pigmenti syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-03-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-02-23" MostRecentSubmission="2024-07-29">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11179023</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9450877</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3124" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2304" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti, familial male-lethal type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bloch-Sulzberger syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti type 2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IP2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Incontinentia pigmenti syndrome</ElementValue>
                <XRef ID="Incontinentia+pigmenti/3798" DB="Genetic Alliance" />
                <XRef ID="367520004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCONTINENTIA PIGMENTI, TYPE II</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IP</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IP2</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6778" />
                <XRef ID="6778" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Incontinentia pigmenti (IP) is a disorder that affects the skin, hair, teeth, nails, eyes, and central nervous system; it occurs primarily in females and on occasion in males. Characteristic skin lesions evolve through four stages: I. Blistering (birth to age ~4 months). II. Wart-like rash (for several months). III. Swirling macular hyperpigmentation (age ~6 months into adulthood). IV. Linear hypopigmentation. Alopecia, hypodontia, abnormal tooth shape, and dystrophic nails are observed. Neovascularization of the retina, present in some individuals, predisposes to retinal detachment. Neurologic findings including seizures, intellectual disability, and developmental delays are occasionally seen.</Attribute>
                <XRef ID="NBK1472" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301645</ID>
                <ID Source="BookShelf">NBK1472</ID>
              </Citation>
              <XRef ID="464" DB="Orphanet" />
              <XRef ID="C0021171" DB="MedGen" />
              <XRef ID="MONDO:0010631" DB="MONDO" />
              <XRef Type="MIM" ID="308300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32447" SubmissionDate="2020-06-09" DateLastUpdated="2024-07-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300248.0012_INCONTINENTIA PIGMENTI" title="IKBKG, 13-BP DUP, NT1166_INCONTINENTIA PIGMENTI" />
        <ClinVarAccession Accession="SCV000032447" DateUpdated="2024-07-29" DateCreated="2013-04-04" Type="SCV" Version="8" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected women from a family (family XL320) with incontinentia pigmenti (IP; 308300), Aradhya et al. (2001) identified a heterozygous 13-bp duplication (c.1166_1178dup) at the end of a cytosine tract (a C(7) tract) in exon 10 of the IKBKG gene. This duplication was predicted to cause a frameshift after amino acid P393 and protein truncation after addition of 4 novel amino acids, resulting in absence of the zinc finger domain. The family had previously been studied by Roberts et al. (1998), who reported that an affected male carrying the hemizygous mutation was carried to term, but died from severe hemorrhage 24 hours after birth. In a subsequent pregnancy, the mother experienced severe bleeding during an elective abortion, suggesting that the mutation in this family disrupted hemostasis.</Attribute>
              <Citation>
                <ID Source="PubMed">11179023</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9450877</ID>
              </Citation>
              <XRef DB="OMIM" ID="308300" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <Name>IKBKG, 13-BP DUP, NT1166</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">13-BP DUP, NT1166</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300248.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INCONTINENTIA PIGMENTI</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32447" TraitType="Disease" MappingType="Name" MappingValue="INCONTINENTIA PIGMENTI" MappingRef="Preferred">
        <MedGen CUI="C0021171" Name="Incontinentia pigmenti syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

